Detail
| LncRNA Name | CTBP |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 M8170/3 |
| Methods | qPCR etc. |
| Sample | HCC tissues |
| Expression Pattern | up-regulated |
| Function Description | We examined RNA-based biomarker panel expression level in 20 paired HCC tissues and adjacent non-tumor tissues by qRT-PCR. In tumor tissues, lncRNA-CTBP, miR-16-2, miR-21-5p expression were at a level higher than that of non-tumor tissues, with the median ratio of 421, 0.26; 12.7, 0.24; and 13.02, 0.28, respectively, compared with normal counterparts. |
| Pubmed ID | 27113935 |
| Year | 2016 |
| Title | Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma. |
| External Links |
| Links for CTBP | GenBank HGNC lncrnadb Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.